Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 29 articles:
HTML format
Text format

Single Articles

    July 2018
    Hepatitis C treatment in Guatemala: the struggle for access.
    Lancet. 2018;392:269-270.
    PubMed     Text format    

    Transforming treatment for hepatitis C.
    Lancet. 2018;392:254.
    PubMed     Text format    

    June 2018
    Hepatitis C-infected organ transplants offer hope.
    Lancet. 2018;391:2485.
    PubMed     Text format    

    March 2018
  4. MOIN A, Fatima H, Qadir TF
    Tackling hepatitis C-Pakistan's road to success.
    Lancet. 2018;391:834-835.
    PubMed     Text format    

    November 2017
  5. GARTNER C, Miller A, Bonevski B
    Extending survival for people with hepatitis C using tobacco dependence treatment.
    Lancet. 2017;390:2033.
    PubMed     Text format    

    July 2017
  6. WIKTOR SZ, Scott JD
    What is the impact of treatment for hepatitis C virus infection?
    Lancet. 2017;390:107-109.
    PubMed     Text format    

  7. DOYLE JS, Thompson AJ, Higgs P, Stoove M, et al
    New hepatitis C antiviral treatments eliminate the virus.
    Lancet. 2017 Jul 6. pii: S0140-6736(17)31817.
    PubMed     Text format    

    February 2017
  8. EKSER B, Mangus RS
    Spontaneous bacterial peritonitis.
    Lancet. 2017;389:735.
    PubMed     Text format    

    January 2017
  9. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    PubMed     Text format     Abstract available

  10. ZEISEL MB, Baumert TF
    Clinical development of hepatitis C virus host-targeting agents.
    Lancet. 2017 Jan 10. pii: S0140-6736(17)30043.
    PubMed     Text format    

    December 2016
    Estimating the burden of hepatitis.
    Lancet. 2016;388:2738-2739.
    PubMed     Text format    

    November 2016
  12. GHINEA N, Lipworth W, Day R, Hill A, et al
    Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.
    Lancet. 2016 Nov 3. pii: S0140-6736(16)32051.
    PubMed     Text format    

    September 2016
    Lasker Foundation announces award winners for 2016.
    Lancet. 2016;388:1144-5.
    PubMed     Text format    

  14. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    PubMed     Text format    

    July 2016
  15. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available

  16. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available

  17. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available

  18. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available

    May 2016
  19. 'T HOEN EF
    Indian hepatitis C drug patent decision shakes public health community.
    Lancet. 2016 May 26. pii: S0140-6736(16)30656.
    PubMed     Text format    

  20. Hepatitis C: global ambition, national realities.
    Lancet. 2016;387:1970.
    PubMed     Text format    

  21. KELLY D
    Hepatitis C viraemia after apparent spontaneous clearance.
    Lancet. 2016;387:1968.
    PubMed     Text format    

  22. INDOLFI G, Mangone G, Bartolini E, Moriondo M, et al
    Hepatitis C viraemia after apparent spontaneous clearance in a vertically infected child.
    Lancet. 2016;387:1967-8.
    PubMed     Text format    

    March 2016
  23. CORRIGAN M, Alrubaiy L, China L
    Hepatology training in the UK.
    Lancet. 2016;387:1055.
    PubMed     Text format    

    January 2016
  24. MCCALL C
    Australia commits funds to curb hepatitis C epidemic.
    Lancet. 2016;387:419.
    PubMed     Text format    

    November 2015
  25. WILLIAMS R, Ashton K, Aspinall R, Bellis MA, et al
    Implementation of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2015;386:2098-111.
    PubMed     Text format    

  26. Hepatitis C: cost of lost opportunities.
    Lancet. 2015;386:1917.
    PubMed     Text format    

    October 2015
  27. JADOUL M, Horsmans Y
    Towards eradication of hepatitis C virus from dialysis units.
    Lancet. 2015 Oct 5. pii: S0140-6736(15)00381.
    PubMed     Text format    

  28. ROTH D, Nelson DR, Bruchfeld A, Liapakis A, et al
    Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.
    Lancet. 2015 Oct 5. pii: S0140-6736(15)00349.
    PubMed     Text format     Abstract available

    August 2015
    Interferon-free treatments against HCV are far from free.
    Lancet. 2015;386:856.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.